Patents by Inventor Steven P. Tanis

Steven P. Tanis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral agents
    Patent number: 6861438
    Abstract: The invention provides a compound of formula I: wherein G, R2, and R3 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: March 1, 2005
    Assignee: Pfizer
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis
  • Antiviral compounds
    Patent number: 6852731
    Abstract: The invention provides a compound of formula I: wherein G, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of preventing or treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: February 8, 2005
    Assignee: Pfizer
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis, James A. Nieman, David John Anderson, Euibong J. Kim, Steven R. Turner
  • 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS
    Publication number: 20040259907
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: December 23, 2004
    Inventors: Michele M. Cudahy, Mark E. Schnute, Steven P. Tanis, William R. Perrault, Paul Matthew Herrinton, Sajiv K. Nair
  • ANTIVIRAL COMPOUNDS
    Publication number: 20040242884
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: December 2, 2004
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis, James A. Nieman, David John Anderson, Euibong J. Kim, Steven R. Turner
  • Process to produce enantiomerically enriched 1-aryl-and 1-heteroaryl-2-aminoethanols
    Publication number: 20040236151
    Abstract: The invention relates to a method of preparing enantiomerically enriched amino alcohols of Formula I 1
    Type: Application
    Filed: March 19, 2004
    Publication date: November 25, 2004
    Applicant: Pfizer, Inc.
    Inventors: Steven P. Tanis, James A. Nieman
  • Process to produce enantiomerically enriched alcohols and amines
    Publication number: 20040230081
    Abstract: This invention describes a convenient method for the preparation and use of a ruthenium catalyst for a chiral reduction of ketones and imines.
    Type: Application
    Filed: March 19, 2004
    Publication date: November 18, 2004
    Applicant: Pfizer, Inc.
    Inventors: Steven P. Tanis, Bruce Evans
  • Antiviral agents
    Publication number: 20040138449
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: July 15, 2004
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis
  • Pyridoquinoxaline antivirals
    Patent number: 6686356
    Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof wherein R1 and R2 are as defined in the specification. The compounds are useful for the treatment of viral infections.
    Type: Grant
    Filed: December 19, 2002
    Date of Patent: February 3, 2004
    Assignee: Pharmacia & Upjohn Company
    Inventors: Joseph Walter Strohbach, Steven P. Tanis, Malcolm Wilson Moon
  • Compounds and methods for diagnosing and treating amyloid-related conditions
    Publication number: 20030219377
    Abstract: The invention provides methods for diagnosing and treating amyloid-related conditions and compounds useful for the same. The invention provides for detecting, imaging, monitoring, diagnosing, and treating conditions characterized by the binding or aggregation of amyloid fibrils. More particularly, the invention relates to using quinolinehydrazone compounds for diagnosing and treating amyloidotic conditions and also as an antioxidant.
    Type: Application
    Filed: April 23, 2003
    Publication date: November 27, 2003
    Applicant: Pharmacia & Upjohn Company
    Inventors: Thomas J. Raub, Geri A. Sawada, Steven P. Tanis, Gregory J. Fici, Allen Edwin Buhl, Donald Bainbridge Carter, Tiziano Bandiera, Jacqueline Lansen, Cesare Pellerano, Luisa Savini
  • Pyridoquinoxaline antivirals
    Publication number: 20030207877
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: December 19, 2002
    Publication date: November 6, 2003
    Inventors: Joseph Walter Strohbach, Steven P. Tanis, Malcolm Wilson Moon, James A. Nieman, Thomas J. Beauchamp, Jill M. Northuis, William D. McGhee
  • PYRIDOQUINOXALINE ANTIVIRALS
    Publication number: 20030130255
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: December 19, 2002
    Publication date: July 10, 2003
    Inventors: Joseph Walter Strohbach, Steven P. Tanis, Malcolm Wilson Moon, William R. Perrault
  • Compounds and methods for diagnosing and treating amyloid-related conditions
    Patent number: 6589504
    Abstract: The invention provides methods for diagnosing and treating amyloid-related conditions and compounds useful for the same. The invention provides for detecting, imaging, monitoring, diagnosing, and treating conditions characterized by the binding or aggregation of amyloid fibrils. More particularly, the invention relates to using quinolinehydrazone compounds for diagnosing and treating amyloidotic conditions and also as an antioxidant.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: July 8, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Thomas J. Raub, Geri A. Sawada, Steven P. Tanis, Gregory J. Fici, Allen Edwin Buhl, Donald Bainbridge Carter, Tiziano Bandiera, Jacqueline Lansen, Cesare Pellerano, Luisa Savini
  • Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
    Publication number: 20020082448
    Abstract: The present invention provide for a method of reducing blood glucose levels in a patient by administering an effective amount of a compound of the formula III or a pharmaceutically acceptable salt thereof; 1
    Type: Application
    Filed: July 13, 2001
    Publication date: June 27, 2002
    Applicant: The Upjohn Company
    Inventors: Scott D. Larsen, Valerie A. Vaillancourt, Paul D. May, Steven P. Tanis, John A. Tucker, Martin D. Meglasson, Heinrich J. Schostarez
  • Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 6329545
    Abstract: The present invention provides novel compounds of the formula I and II for the treatment of non-insulin dependent diabetes mellitius (NIDDM) and a new use of known compounds for this purpose.
    Type: Grant
    Filed: November 8, 1999
    Date of Patent: December 11, 2001
    Inventors: Scott D. Larsen, Valerie A. Vaillancourt, Paul D. May, Steven P. Tanis, John A. Tucker, Martin D. Meglasson, Heinrich J. Schostarez
  • Aminoquanidine carboxylates for the treatment of obesity
    Patent number: 6166080
    Abstract: The present invention provides novel compounds of the formulae (I): AG--(CH.sub.2).sub.n --CO.sub.2 R.sup.1 and (II) or pharmacologically acceptable salts thereof, wherein AG is: a) N-aminoguanidine, b) N,N'-diaminoguanidine, or c) N,N',N"-triaminoguanidine; and n, R.sup.1 and R.sup.2 have the meanings given in the description as well as a new use for the compounds of formula (III) wherein R.sup.3 has the meanings given in the description for the treatment of non-insulin dependent diabetes mellitus (NIDDM).
    Type: Grant
    Filed: May 22, 1997
    Date of Patent: December 26, 2000
    Assignee: Pharmacia
    Inventors: Scott D. Larsen, Paul D. May, Steven P. Tanis, Valerie A. Vaillancourt, John A. Tucker, Heinrich J. Schostarez, Martin D. Meglasson
  • Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
    Patent number: 5994577
    Abstract: The present invention provides novel compounds of the formula I and II for the treatment of non-insulin dependent diabetes mellitius (NIDDM) and a new use of known compounds for this purpose.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 30, 1999
    Inventors: Scott D. Larsen, Valerie A. Vaillancourt, Paul D. May, Steven P. Tanis, John A. Tucker, Martin D. Meglasson, Heinrich J. Schostarez
  • .alpha.-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
    Patent number: 5245046
    Abstract: Provided are novel .alpha.-aminoindole-3-acetic acid derivatives having the formula ##STR1## wherein R through R9 are as defined in the specification, and pharmacologically acceptable salts of compounds wherein R.sub.9 is not OM, which are useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents.
    Type: Grant
    Filed: May 8, 1991
    Date of Patent: September 14, 1993
    Assignee: The Upjohn Company
    Inventors: Gilbert A. Youngdale, John C. Sih, Steven P. Tanis, Chiu-Hong Lin